...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>AIDS care. >Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
【24h】

Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.

机译：感染了艾滋病毒和丙型肝炎或仅丙型肝炎的注射吸毒者在获得护理方面的差异。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Access to HCV (Hepatitis C virus) care for HIV/HCV-co-infected patients is an urgent public health concern. The objective of the present study was to describe the self-reported health status of HIV/HCV-co-infected and HCV-mono-infected injection drug users and to describe their access to HCV-related care. Beginning in May 1996, persons who had injected illicit drugs in the previous month were recruited into the Vancouver Injection Drug User Study (VIDUS). At baseline and then semi-annually, participants complete an interviewer-administered questionnaire. Blood is drawn at each semi-annual interview and tested for HIV and Hepatitis C infection. Data for this descriptive, cross-sectional study were drawn from the most recent of either the July 2003 or December 2003 nurse-administered questionnaire. Statistics used were the chi-square, Wilcoxon Rank Sum and Student's t-test. Logistic regression was used to examine factors independently associated with accessing HCV care. There were 707 individuals eligible for this analysis, including 240 HIV/HCV-co-infected and 467 HCV-mono-infected persons. Co-infected individuals were more likely to be female, younger, of Aboriginal ethnicity and less likely to use heroin daily. The HCV-mono-infected group tended to report higher rates of HCV-related symptoms, including fatigue, liver pain, nausea, night-sweats and stomach pain. However, it was the HIV/HCV-co-infected group who were more likely to report that they believed their hepatitis C was affecting them. The HIV/HCV-co-infected group were also more likely to report having received any hepatitis-related follow-up care, including blood work, liver biopsies and referrals to specialists. In logistic regression analysis, factors independently associated with ever receiving any hepatitis C related follow-up were HIV/HCV-co-infection (AOR 3.1; 95% CI: 2-4.7), being older (AOR 1.04; 95% CI: 1.02-1.06 per year older), using heroin daily (AOR 0.54; 95% CI: 0.36-0.82) and believing that hepatitis C was affecting one's health (AOR 1.4; 95% CI: 1.0-2.1). In conclusion, our data indicate more HCV healthcare utilization among those HIV/HCV-co-infected.
机译：HIV / HCV合并感染患者获得HCV（丙型肝炎病毒）护理是一项迫切的公共健康问题。本研究的目的是描述HIV / HCV合并感染和HCV单感染的注射吸毒者的自我报告的健康状况，并描述他们获得HCV相关护理的机会。从1996年5月开始，将前一个月注射非法药物的人员纳入温哥华注射毒品使用者研究（VIDUS）。在基线时，然后每半年一次，参与者填写由访调员管理的问卷。在每半年一次的面试中抽取血液，并进行HIV和丙型肝炎感染检测。该描述性横断面研究的数据来自2003年7月或2003年12月护士管理的问卷中的最新数据。使用的统计数据是卡方，Wilcoxon秩和和学生t检验。 Logistic回归用于检验与获得HCV护理独立相关的因素。有707个人符合此分析的条件，其中包括240例HIV / HCV合并感染者和467例HCV单一感染者。合并感染的人更有可能是女性，更年轻的原住民，并且每天使用海洛因的可能性也较小。感染HCV的人群倾向于报告HCV相关症状的发生率更高，包括疲劳，肝痛，恶心，夜间出汗和胃痛。但是，更容易报告他们相信自己的丙型肝炎正在影响他们的是HIV / HCV合并感染的人群。 HIV / HCV合并感染组也更有可能报告曾接受过任何与肝炎相关的后续护理，包括血液检查，肝活检和转诊给专家。在逻辑回归分析中，与接受丙型肝炎相关随访无关的独立因素是HIV / HCV合并感染（AOR 3.1; 95％CI：2-4.7），年龄较大（AOR 1.04; 95％CI：1.02） -1.06岁/年长），每天使用海洛因（AOR 0.54; 95％CI：0.36-0.82），并相信丙型肝炎正在影响一个人的健康（AOR 1.4; 95％CI：1.0-2.1）。总之，我们的数据表明，在合并感染了HIV / HCV的人群中，HCV医疗保健的利用率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号